Skip to content
★ Sign in to follow
CB

Charles Bisgaier PhD

MetaVia Inc.Theriva Biologics, Inc.
Total declarations
11
Companies
2
▲ Purchases (2 ops.)
€496k
▼ Sales (0 ops.)
—

Latest filing published 26 Jul 2019 for MetaVia Inc..

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

Closed purchases

Market purchases
2

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 12 Aug 2016 · 3741 days ago · €463k
    -12.1%
    Entry US$667,920.00 · Close at T+365 US$587,400.00

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Charles Bisgaier PhD: trading record in brief

Charles Bisgaier PhD is a declared insider at 2 companies; the most frequent names are MetaVia Inc. and Theriva Biologics, Inc. Between 2 November 2006 and 24 July 2019, the trades on record add up to 11 filings.

The open-market record is one-sided, with 2 purchases worth €496k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 4 share grants and 1 option exercise.

On 26 July 2019 came the latest disclosure, a share grant in MetaVia Inc. The last purchase on record was published on 12 August 2016, which is 3,741 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Charles Bisgaier PhD

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations10 total

10 of 10 declarations